{
  "id": "mhgap#risk_safety_7c9887e9",
  "content": "treatment plan. Additionally, carer preference\nRemarks should be taken into consideration.\ny The medicines included in the recommendation y Furthermore, given the higher susceptibility of\ncorrespond to the WHO EML (13) and are listed in adolescents to side-effects, the medicines approved\nalphabetical order. in a given country should be carefully considered\ny Clozapine should only be offered where lab tests before formulating a treatment plan.\nare available to monitor white blood cell count, and\nunder a mental health specialist’s supervision.\nPSY6. Is psychotropic medicine effective and safe for adolescents\nwith bipolar disorder?\nRecommendation (update): Psychotropic medicines (antipsychotic medicines, namely aripiprazole,\nolanzapine, quetiapine, risperidone; and mood stabilizers, namely lithium)\nshould be considered under specialist supervision for adolescents with\nbipolar disorder (current episode manic), carefully balancing effectiveness,\nside-effects and individual preference.\nStrength of recommendation: Conditional\nCertainty of evidence: Very low\nJustification trials in children and adolescents with bipolar\ny Evidence was extracted from two systematic reviews: disorder manic episode) (201).\nDelBello et al., 2022 (4 RCTs in an NMA of efficacy and y Few antipsychotics/mood stabilizers have been\nsafety of second-generation antipsychotic medicines tested in children and adolescents. The medicines",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "risk_safety",
      "referral",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Risk Safety treatment plan. Additionally, carer preference\nRemarks should be taken into consideration.\ny The medicines included in the recommendation y Furthermore, given the higher susceptibility of\ncorrespond to the WHO EML (13) and are listed in adolescents to side-effects, the medicines approved\nalphabetical order. in a given country should be carefully considered\ny Clozapine should only be offered where lab tests before formulating a treatment plan.\nare available to monitor white blood cell count, and\nunder a mental health specialist’s supervision.\nPSY6. Is psychotropic medicine effective and safe for adolescents\nwith bipolar disorder?\nRecommendation (update): Psychotropic medicines (antipsychotic medicines, namely aripiprazole,\nolanzapine, quetiapine, risperidone; and mood stabilizers, namely lithium)\nshould be considered under specialist supervision for adolescents with\nbipolar disorder (current episode manic), carefully balancing effectiveness,\nside-effects and individual preference.\nStrength of recommendation: Conditional\nCertainty of evidence: Very low\nJustification trials in children and adolescents with bipolar\ny Evidence was extracted from two systematic reviews: disorder manic episode) (201).\nDelBello et al., 2022 (4 RCTs in an NMA of efficacy and y Few antipsychotics/mood stabilizers have been\nsafety of second-generation antipsychotic medicines tested in children and adolescents. The medicines Treatment plan. additionally, carer preference\nremarks should be taken into consideration."
}